Literature DB >> 16112545

Aerodynamic analysis of male-to-female transgender voice.

Mary Gorham-Rowan1, Richard Morris.   

Abstract

The attainment of a feminine-sounding voice is a highly desirable goal among male-to-female transgender (MFT) persons, but this goal may be difficult for many to accomplish. The characteristics associated with a feminine vocal quality include increases in fundamental frequency and in vocal breathiness. In this study, we used inverse-filtering of the airflow signal to indirectly assess vocal fold function in 13 MFT persons. Each participant was asked to sustain the vowel /a/ first in her biological male voice and then again in her female voice. In addition, these vowel productions were compared with vowels produced by age-matched biologic women and men. The results of the study revealed a significant increase in maximum flow declination rate during female voice production. Perceptual ratings of a feminine voice were associated with a fundamental frequency (F0) of 180 Hz or greater, although F0 did not differ significantly between male and female voice production. These results are discussed relative to the mechanisms that obtained a feminine-sounding voice.

Entities:  

Mesh:

Year:  2005        PMID: 16112545     DOI: 10.1016/j.jvoice.2005.03.004

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  3 in total

1.  Unsteady laryngeal airflow simulations of the intra-glottal vortical structures.

Authors:  Mihai Mihaescu; Sid M Khosla; Shanmugam Murugappan; Ephraim J Gutmark
Journal:  J Acoust Soc Am       Date:  2010-01       Impact factor: 1.840

2.  Examining the voice of Israeli transgender women: Acoustic measures, voice femininity and voice-related quality-of-life.

Authors:  Noa Diamant; Ofer Amir
Journal:  Int J Transgend Health       Date:  2020-08-07

Review 3.  Vocal Feminization for Transgender Women: Current Strategies and Patient Perspectives.

Authors:  Hyung-Tae Kim
Journal:  Int J Gen Med       Date:  2020-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.